BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Diagnosis
25 results:

  • 1. Molecular Features of Resected Melanoma brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
    Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
    JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. brain metastases of papillary thyroid carcinoma origin are derived from aggressive histologic variants and demonstrate similar adverse morphology in the metastatic lesion.
    Gubbiotti MA; Livolsi V
    Clin Neurol Neurosurg; 2023 Apr; 227():107639. PubMed ID: 36889238
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Thyroid carcinoma metastases to central nervous system and vertebrae.
    Kleinschmidt-DeMasters B; Marshall C
    Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III.
    Wang Y; Lian B; Si L; Mao L; Chi Z; Sheng X; Kong Y; Wang X; Bai X; Yan X; Li S; Tang B; Dai J; Zhou L; Wei X; Cui C; Guo J
    Eur J Cancer; 2022 Nov; 175():196-203. PubMed ID: 36137395
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma.
    Zhang Q; Sun Y; Wang C; Shao F
    Bioengineered; 2022 Mar; 13(3):6258-6271. PubMed ID: 35212617
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing.
    Yim J; Koh J; Kim S; Song SG; Bae JM; Yun H; Sung JY; Kim TM; Park SH; Jeon YK
    Am J Surg Pathol; 2022 Apr; 46(4):486-497. PubMed ID: 34980830
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.
    Makino Y; Arakawa Y; Yoshioka E; Shofuda T; Minamiguchi S; Kawauchi T; Tanji M; Kanematsu D; Nonaka M; Okita Y; Kodama Y; Mano M; Hirose T; Mineharu Y; Miyamoto S; Kanemura Y
    BMC Cancer; 2021 Sep; 21(1):1025. PubMed ID: 34525976
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Giant lung metastasis of nras-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.
    Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R
    Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Testing for
    Le Flahec G; Briolais M; Guibourg B; Lemasson G; Grippari JL; Ledé F; Marcorelles P; Uguen A
    J Clin Pathol; 2020 Feb; 73(2):116-119. PubMed ID: 31506288
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Survival and prognostic factors in surgically treated brain metastases.
    Kavouridis VK; Harary M; Hulsbergen AFC; Lo YT; Reardon DA; Aizer AA; Iorgulescu JB; Smith TR
    J Neurooncol; 2019 Jun; 143(2):359-367. PubMed ID: 30989623
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.
    Núñez FJ; Mendez FM; Kadiyala P; Alghamri MS; Savelieff MG; Garcia-Fabiani MB; Haase S; Koschmann C; Calinescu AA; Kamran N; Saxena M; Patel R; Carney S; Guo MZ; Edwards M; Ljungman M; Qin T; Sartor MA; Tagett R; Venneti S; Brosnan-Cashman J; Meeker A; Gorbunova V; Zhao L; Kremer DM; Zhang L; Lyssiotis CA; Jones L; Herting CJ; Ross JL; Hambardzumyan D; Hervey-Jumper S; Figueroa ME; Lowenstein PR; Castro MG
    Sci Transl Med; 2019 Feb; 11(479):. PubMed ID: 30760578
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. nras
    Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
    Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
    Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
    Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Intraventricular melanocytoma diagnosis confirmed by gene mutation profile.
    Knappe UJ; Tischoff I; Tannapfel A; Reinbold WD; Möller I; Sucker A; Schadendorf D; Griewank KG; van de Nes JAP
    Neuropathology; 2018 Jun; 38(3):288-292. PubMed ID: 29226425
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
    Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
    Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Prognostic Value of BRAF, C-KIT, and nras Mutations in Melanoma Patients With brain Metastases.
    Sperduto PW; Jiang W; Brown PD; Braunstein S; Sneed P; Wattson DA; Shih HA; Bangdiwala A; Shanley R; Lockney NA; Beal K; Lou E; Amatruda T; Sperduto WA; Kirkpatrick JP; Yeh N; Gaspar LE; Molitoris JK; Masucci L; Roberge D; Yu J; Chiang V; Mehta M
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1069-1077. PubMed ID: 28721890
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk factors for brain metastases in patients with metastatic colorectal cancer.
    Christensen TD; Palshof JA; Larsen FO; Høgdall E; Poulsen TS; Pfeiffer P; Jensen BV; Yilmaz MK; Christensen IJ; Nielsen D
    Acta Oncol; 2017 May; 56(5):639-645. PubMed ID: 28447565
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Melanoma in congenital melanocytic naevi.
    Kinsler VA; O'Hare P; Bulstrode N; Calonje JE; Chong WK; Hargrave D; Jacques T; Lomas D; Sebire NJ; Slater O
    Br J Dermatol; 2017 May; 176(5):1131-1143. PubMed ID: 28078671
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mutation analysis of metastatic melanomas in the central nervous system: results of a panel of 5 genes in 48 cases.
    Gamsizkan M; Yilmaz I; Simsek HA; Onguru O; Griffin A; Tihan T
    Clin Neuropathol; 2016; 35(4):178-85. PubMed ID: 27117140
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Systematic review: brain metastases from colorectal cancer--Incidence and patient characteristics.
    Christensen TD; Spindler KL; Palshof JA; Nielsen DL
    BMC Cancer; 2016 Apr; 16():260. PubMed ID: 27037031
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.